Promethera Biosciences
Belgium · $44.4M raised
- Employees
- 11–50
- Business Model
- B2B
- Website
- cellaion.com
- Total Funding
- $44.4M
- Last Round
- $44.4M Series DMay 2019
- Rounds
- 3
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 3 funding rounds and 1 investor for this company. The full record is or through the API.
About
Pioneer in developing therapies to reduce liver transplantation needs
Summary
Promethera Biosciences is a Biotech company based in Belgium. It has raised $44.4M in total across 3 rounds, most recently a $44.4M Series D round in May 2019. Investors include SFPI-FPIM.
Tech & App Stack
1 technology or app tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
May 2019
Sign up to see all 3 events
Funding: Series B through Series D. Amounts, valuations, and investors where available.
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/promethera-biosciences"><img src="https://indexed.vc/api/badge/company/promethera-biosciences" alt="Promethera Biosciences on Indexed.vc" width="260" height="76" /></a>